ALMS
NASDAQ · Pharmaceuticals
Alumis Inc
$6.03
+0.18 (+3.08%)
Performance
1D
+0.00%
1W
-5.49%
1M
-13.49%
3M
-78.10%
6M
-74.51%
1Y
+27.75%
YTD
-32.66%
Open$5.88
Previous Close$5.85
Day High$6.08
Day Low$5.82
52W High$31.35
52W Low$4.40
Volume—
Avg Volume1.98M
Market Cap780.95M
P/E Ratio—
EPS$-3.81
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$8.13
Below
SMA 200
$20.94
Below
RSI (14)
45.2
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
16 analysts
Price Target
+306.5% upside
Current
$6.03
$6.03
Target
$24.51
$24.51
$15.34
$24.51 avg
$36.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 36.63M | 878.33M | 917.39M |
| Net Income | -370,606,461 | 120.27M | 166.79M |
| Profit Margin | -1,011.8% | 13.7% | 18.2% |
| EBITDA | -399,668,556 | 272.46M | 241.94M |
| Free Cash Flow | — | 126.96M | 147.40M |
| Rev Growth | — | +6.0% | +16.1% |
| Debt/Equity | — | 0.25 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |